Cases
Search U.S. court opinions (CourtListener / Free Law Project), or resolve a reporter citation to its case via the Caselaw Access Project. Facts only — name, court, date, status, citation count. Never a holding-summary.
5 opinions for “Conde v. Janssen Research & Developement LLC”
Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLCpublic domain
Lourie, Circuit Judge. Plaintiffs-Appellants (collectively, "Sanofi") appeal from the judgment of the U.S. District Court for the District of New Jersey holding, after a bench trial, claims 7, 11, 14-16, and 26 of U.S. Patent 8,927,592 (the " '592 patent") invalid as obvious. Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA, LLC , No. 14-7869 (D.N.J. Dec. 19, 2017) ("
Pernix Ir. Pain Dac v. Alvogen Malta Operations Ltd.public domain
WILLIAM C. BRYSON, UNITED STATES CIRCUIT JUDGE *572BACKGROUND This is a Hatch-Waxman Act case. The plaintiffs, Pernix Ireland Pain DAC and Pernix Therapeutics, LLC, (collectively, "Pernix") have sued the defendant, Alvogen Malta Operations Ltd. ("Alvogen") for patent infringement under
Apotex, Inc. v. Daiichi Sankyo, Inc.public domain
TARANTO, Circuit Judge. Apotex, Inc. brought this action against Daiichi Sankyo Co., Ltd. and Daiichi Sank-yo, Inc. (collectively, Daiichi) to obtain a declaratory judgment that Apotex will not infringe a patent owned but disclaimed by Daiichi if Apotex manufactures or sells a generic drug bioequivalent to Daiichi’s Be-nicar®. Apotex cannot infringe the patent, because Daiichi
East Texas Medical Center Gilmer v. Birder Porterpublic domain
ACCEPTED 12-14-00220-CV TWELFTH COURT OF APPEALS TYLER, TEXAS 9/4/2015 3:01:53 PM
ACCEPTED 03-14-00510-CV 4243321 THIRD COURT OF APPEALS AUSTIN, TEXAS